An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

18 páginas, 2 tablas, 1 figura.

Saved in:
Bibliographic Details
Main Authors: Krolewiecki, A., Enbiale, W., Gandasegui, J., van Lieshout, L., Kepha, S., Messa Junior, A., Bengtson, M., Gelaye, W., Escola, V., Martinez Valladares, María, Cambra-Pellejà, M., Algorta, J., Martí-Soler, H., Fleitas, P., Ballester, M.R., Doyle, S.R., Williams, N.A., Legarda, A., Mandomando, I., Mwandawiro, C., Muñoz, J.
Format: artículo biblioteca
Published: Taylor & Francis 2022
Subjects:Antihelmintics, STH, Trichuris trichiura, Strongyloides, Hookworm, Albendazole, Ivermectin,
Online Access:http://hdl.handle.net/10261/303408
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:18 páginas, 2 tablas, 1 figura.

Similar Items